申请人:Sage Therapeutics, Inc.
公开号:US20170342103A1
公开(公告)日:2017-11-30
Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (I) and (III):
where R
1
, R
2
, R
3
, R
3′
, R
4
, R
6a
, R
6a
, R
11a
, and R
11b
are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, insomnia, anxiety, depression, traumatic brain injury (TBI), stress, and epilepsy.